[{"Id":51,"VaccineAbbreviation":"DTaP-IPV-Hib-HepB4","TargetDiseaseCode":"105","AgeGroup":"3a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"3-aastaste arv, kellele on manustatud 4 doosi difteeria, teetanuse, polio, Hib, B-viirushepatiit ja läkaköha komponenti sisaldavat vaktsiini vanuses 0-3 aastat/3-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 3-year-olds who have received 4 doses of a vaccine containing diphtheria, tetanus, polio, Hib, hepatitis B and pertussis components aged 0-3 years/number of 3-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":39,"VaccineAbbreviation":"MMR2","TargetDiseaseCode":"106","AgeGroup":"18a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"18-aastaste arv, kellele on manustatud 2 doosi MMR vaktsiini vanuses 1-18 aastat/18-aastaste arv *100","VaccineAbbreviationsDescriptionEng":"Number of 18-year-olds who have received 2 doses of MMR vaccine aged 1-18 years/number of 18-year-olds *100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":49,"VaccineAbbreviation":"DTaP-IPV-Hib-HepB4","TargetDiseaseCode":"102","AgeGroup":"3a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"3-aastaste arv, kellele on manustatud 4 doosi difteeria, teetanuse, polio, Hib, B-viirushepatiit ja läkaköha komponenti sisaldavat vaktsiini vanuses 0-3 aastat/3-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 3-year-olds who have received 4 doses of a vaccine containing diphtheria, tetanus, polio, Hib, hepatitis B and pertussis components aged 0-3 years/number of 3-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":9,"VaccineAbbreviation":"HepB3","TargetDiseaseCode":"101","AgeGroup":"7a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"7-aastaste arv, kellele on manustatud vähemalt 3 doosi vaktsiini Engerix B või 4 doosi DTaP-IPV-Hib-HepB vaktsiini vanues 0-7 aastat /7-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 7-year-olds who have received at least 3 doses of Engerix B vaccine or 4 doses of DTaP-IPV-Hib-HepB vaccine at the age of 0-7 years /number of 7-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":50,"VaccineAbbreviation":"DTaP-IPV-Hib-HepB4","TargetDiseaseCode":"109","AgeGroup":"3a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"3-aastaste arv, kellele on manustatud 4 doosi difteeria, teetanuse, polio, Hib, B-viirushepatiit ja läkaköha komponenti sisaldavat vaktsiini vanuses 0-3 aastat/3-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 3-year-olds who have received 4 doses of a vaccine containing diphtheria, tetanus, polio, Hib, hepatitis B and pertussis components aged 0-3 years/number of 3-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":46,"VaccineAbbreviation":"DTaP-IPV-Hib-HepB3","TargetDiseaseCode":"105","AgeGroup":"2a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"2-aastaste arv, kellele on manustatud 3 doosi difteeria, teetanuse, polio, Hib, B-viirushepatiit ja läkaköha komponenti sisaldavat vaktsiini vanuses 0-2 aastat/2-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 2-year-olds who have received 3 doses of a vaccine containing diphtheria, tetanus, polio, Hib, hepatitis B and pertussis components aged 0-2 years/number of 2-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":53,"VaccineAbbreviation":"DTaP-IPV-Hib-HepB4","TargetDiseaseCode":"107","AgeGroup":"3a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"3-aastaste arv, kellele on manustatud 4 doosi difteeria, teetanuse, polio, Hib, B-viirushepatiit ja läkaköha komponenti sisaldavat vaktsiini vanuses 0-3 aastat/3-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 3-year-olds who have received 4 doses of a vaccine containing diphtheria, tetanus, polio, Hib, hepatitis B and pertussis components aged 0-3 years/number of 3-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":8,"VaccineAbbreviation":"IPV5","TargetDiseaseCode":"107","AgeGroup":"7a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"7-aastaste arv, kellele on manustatud vähemalt 5 doosi poliomüeliidi komponendi sisaldava vaktsiini vanuses 0-7 aastat, kus viimane doos oli manustatud vanuses 6-7 aastat/7-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 7-year-olds who have received at least 5 doses of polio-containing vaccine at the age of 0-7 years, where the last dose was administered at the age of 6-7 years/number of 7-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":47,"VaccineAbbreviation":"DTaP-IPV-Hib-HepB3","TargetDiseaseCode":"101","AgeGroup":"2a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"2-aastaste arv, kellele on manustatud 3 doosi difteeria, teetanuse, polio, Hib, B-viirushepatiit ja läkaköha komponenti sisaldavat vaktsiini vanuses 0-2 aastat/2-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 2-year-olds who have received 3 doses of a vaccine containing diphtheria, tetanus, polio, Hib, hepatitis B and pertussis components aged 0-2 years/number of 2-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":29,"VaccineAbbreviation":"MMR1","TargetDiseaseCode":"104","AgeGroup":"8a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"8-aastaste arv, kellele on manustatud 1 doos leetrite, mumpsi ja punetiste komponenti sisaldavat vaktsiini vanuses 1-8 aastat/8-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 8-year-olds who have received 1 dose of measles, mumps, and rubella vaccine aged 1-8 years/number of 8-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":41,"VaccineAbbreviation":"BCG ","TargetDiseaseCode":"110","AgeGroup":"0a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"0-11-kuuste arv, kellele on manustatud tuberkuloosi vaktsiini BCG/0-11-kuuste arv*100","VaccineAbbreviationsDescriptionEng":"Number of children aged 0-11 months who have received the BCG tuberculosis vaccine/number of children aged 0-11 months*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":13,"VaccineAbbreviation":"HPV1","TargetDiseaseCode":"203","AgeGroup":"12a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"12-aastaste arv, kes said HPV1 vaktsiini (Gardasil9)/12-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 12-year-olds who received HPV1 vaccine (Gardasil9)/Number of 12-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":52,"VaccineAbbreviation":"DTaP-IPV-Hib-HepB4","TargetDiseaseCode":"101","AgeGroup":"3a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"3-aastaste arv, kellele on manustatud 4 doosi difteeria, teetanuse, polio, Hib, B-viirushepatiit ja läkaköha komponenti sisaldavat vaktsiini vanuses 0-3 aastat/3-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 3-year-olds who have received 4 doses of a vaccine containing diphtheria, tetanus, polio, Hib, hepatitis B and pertussis components aged 0-3 years/number of 3-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":43,"VaccineAbbreviation":"TBE","TargetDiseaseCode":"211","AgeGroup":"18+","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"18+ inimeste arv, kes on saanud viimase 5 aasta jooksul puukentsefaliidi vaktsiini ≥4 doosi (TicoVac; Encepur)","VaccineAbbreviationsDescriptionEng":"Number of people 18+ who have received ≥4 doses of tick-borne encephalitis vaccine (TicoVac; Encepur) in the last 5 years","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":17,"VaccineAbbreviation":"HPV1","TargetDiseaseCode":"203","AgeGroup":"13a","Gender":"Male","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"13-aastaste poiste arv, kes said HPV1 vaktsiini (Gardasil9)/13-aastaste poiste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 13-year-old boys who received HPV1 vaccine (Gardasil9)/Number of 13-year-old boys*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":10,"VaccineAbbreviation":"HepB3","TargetDiseaseCode":"101","AgeGroup":"8a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"8-aastaste arv, kellele on manustatud vähemalt 3 doosi vaktsiini Engerix B või 4 doosi DTaP-IPV-Hib-HepB vaktsiini vanuses 0-8 aastat/8-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 8-year-olds who have received at least 3 doses of Engerix B vaccine or 4 doses of DTaP-IPV-Hib-HepB vaccine aged 0-8 years/number of 8-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":4,"VaccineAbbreviation":"dTap","TargetDiseaseCode":"105","AgeGroup":"18a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"18-aastaste arv, kellele on manustatud 6 doosi läkaköha komponenti sisaldavat vaktsiini vanuses 0-18 aastat/15-18-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 18-year-olds who have received 6 doses of a vaccine containing the pertussis component aged 0-18 years/number of 15-18 year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":3,"VaccineAbbreviation":"dTap","TargetDiseaseCode":"105","AgeGroup":"16a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"16-aastaste arv, kellele on manustatud 6 doosi läkaköha komponenti sisaldavat vaktsiini vanuses 0-16 aastat/16-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 16-year-olds who have received 6 doses of a vaccine containing the pertussis component aged 0-16 years/number of 16-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":18,"VaccineAbbreviation":"HPV1","TargetDiseaseCode":"203","AgeGroup":"14a","Gender":"Male","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"14-aastaste poiste arv, kes said HPV1 vaktsiini (Gardasil9)/14-aastaste poiste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 14-year-old boys who received HPV1 vaccine (Gardasil9)/Number of 14-year-old boys*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":11,"VaccineAbbreviation":"HepB3","TargetDiseaseCode":"101","AgeGroup":"16a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"16-aastaste arv, kellele on manustatud vähemalt 3 doosi vaktsiini Engerix B või 4 doosi DTaP-IPV-Hib-HepB vaktsiini vanuses 0-16 aastat/16-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 16-year-olds who have received at least 3 doses of Engerix B vaccine or 4 doses of DTaP-IPV-Hib-HepB vaccine aged 0-16 years/number of 16-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":23,"VaccineAbbreviation":"MMR1","TargetDiseaseCode":"104","AgeGroup":"2a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"2-aastaste arv, kellele on manustatud 1 doos leetrite, mumpsi ja punetiste komponenti sisaldavat vaktsiini vanuses 1-2 aastat/2-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 2-year-olds who have received 1 dose of measles, mumps, and rubella-containing vaccine at ages 1-2 years/number of 2-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":28,"VaccineAbbreviation":"MMR1","TargetDiseaseCode":"108","AgeGroup":"7a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"7-aastaste arv, kellele on manustatud 1 doos leetrite, mumpsi ja punetiste komponenti sisaldavat vaktsiini vanuses 1-7 aastat/7-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 7-year-olds who have received 1 dose of measles, mumps, and rubella vaccine aged 1-7 years/number of 7-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":26,"VaccineAbbreviation":"MMR1","TargetDiseaseCode":"104","AgeGroup":"7a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"7-aastaste arv, kellele on manustatud 1 doos leetrite, mumpsi ja punetiste komponenti sisaldavat vaktsiini vanuses 1-7 aastat/7-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 7-year-olds who have received 1 dose of measles, mumps, and rubella vaccine aged 1-7 years/number of 7-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":30,"VaccineAbbreviation":"MMR1","TargetDiseaseCode":"106","AgeGroup":"8a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"8-aastaste arv, kellele on manustatud 1 doos leetrite, mumpsi ja punetiste komponenti sisaldavat vaktsiini vanuses 1-8 aastat/8-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 8-year-olds who have received 1 dose of measles, mumps, and rubella vaccine aged 1-8 years/number of 8-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":27,"VaccineAbbreviation":"MMR1","TargetDiseaseCode":"106","AgeGroup":"7a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"7-aastaste arv, kellele on manustatud 1 doos leetrite, mumpsi ja punetiste komponenti sisaldavat vaktsiini vanuses 1-7 aastat/7-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 7-year-olds who have received 1 dose of measles, mumps, and rubella vaccine aged 1-7 years/number of 7-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":12,"VaccineAbbreviation":"HepB3","TargetDiseaseCode":"101","AgeGroup":"18a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"18-aastaste arv, kellele on manustatud vähemalt 3 doosi vaktsiini Engerix B või 4 doosi DTaP-IPV-Hib-HepB vaktsiini vanuses 0-18 aastat/18-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 18-year-olds who have received at least 3 doses of Engerix B vaccine or 4 doses of DTaP-IPV-Hib-HepB vaccine aged 0-18 years/number of 18-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":1,"VaccineAbbreviation":"dT","TargetDiseaseCode":"102","AgeGroup":"18+","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"18+ inimeste arv kes on saanud viimase 10 aasta jooksul difteeria ja teetanuse komponenti sisaldavat vaktsiini (Boostrix; Adacel; Imovax d.T. Adult; Tetraxim)","VaccineAbbreviationsDescriptionEng":"Number of people 18+ who have received a vaccine containing a diphtheria and tetanus component (Boostrix; Adacel; Imovax d.T. Adult; Tetraxim) in the last 10 years","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":21,"VaccineAbbreviation":"HPV1","TargetDiseaseCode":"203","AgeGroup":"14a","Gender":"Female","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"14-aastaste tütarlaste arv, kes said HPV1 vaktsiini (Gardasil9)/14-aastaste tütarlaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 14-year-old girls who received HPV1 vaccine (Gardasil9)/Number of 14-year-old girls*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":44,"VaccineAbbreviation":"DTaP-IPV-Hib-HepB3","TargetDiseaseCode":"102","AgeGroup":"2a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"2-aastaste arv, kellele on manustatud 3 doosi difteeria, teetanuse, polio, Hib, B-viirushepatiit ja läkaköha komponenti sisaldavat vaktsiini vanuses 0-2 aastat/2-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 2-year-olds who have received 3 doses of a vaccine containing diphtheria, tetanus, polio, Hib, hepatitis B and pertussis components aged 0-2 years/number of 2-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":42,"VaccineAbbreviation":"Rvfull","TargetDiseaseCode":"111","AgeGroup":"1a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"1-aastaste arv, kellele on manustatud vanuses 0-6 kuud rotaviiruse vaktsiini (Rota Teq 3.doos või Rotarix 2.doos) /1-aastaste arv*100:","VaccineAbbreviationsDescriptionEng":"Number of 1-year-olds who have been administered rotavirus vaccine (Rota Teq 3rd dose or Rotarix 2nd dose) at the age of 0-6 months /number of 1-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":36,"VaccineAbbreviation":"MMR2","TargetDiseaseCode":"106","AgeGroup":"16a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"16-aastaste arv, kellele on manustatud 2 doosi MMR vaktsiini vanuses 1-16 aastat/16-aastaste arv *100","VaccineAbbreviationsDescriptionEng":"Number of 16-year-olds who have received 2 doses of MMR vaccine aged 1-16 years/number of 16-year-olds *100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":22,"VaccineAbbreviation":"HPV2","TargetDiseaseCode":"203","AgeGroup":"19-26","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"19-26 aastaste arv, kes said HPV2 vaktsiini (Gardasil9)/19-26-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 19-26 year olds who received HPV2 vaccine (Gardasil9)/number of 19-26 year olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":7,"VaccineAbbreviation":"dTap5","TargetDiseaseCode":"109","AgeGroup":"7a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"7-aastaste arv, kellele on manustatud vähemalt 5 doosi difteeria, teetanuse ja läkaköha komponentide sisaldava vaktsiini vanuses 0-7-aastat, kus viimane doos oli manustatud vanuses 6-7 aastat /7-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 7-year-olds who have received at least 5 doses of a vaccine containing diphtheria, tetanus and pertussis components between the ages of 0-7 years, where the last dose was administered between the ages of 6-7 years /number of 7-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":37,"VaccineAbbreviation":"MMR2","TargetDiseaseCode":"108","AgeGroup":"16a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"16-aastaste arv, kellele on manustatud 2 doosi MMR vaktsiini vanuses 1-16 aastat/16-aastaste arv *100","VaccineAbbreviationsDescriptionEng":"Number of 16-year-olds who have received 2 doses of MMR vaccine aged 1-16 years/number of 16-year-olds *100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":45,"VaccineAbbreviation":"DTaP-IPV-Hib-HepB3","TargetDiseaseCode":"109","AgeGroup":"2a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"2-aastaste arv, kellele on manustatud 3 doosi difteeria, teetanuse, polio, Hib, B-viirushepatiit ja läkaköha komponenti sisaldavat vaktsiini vanuses 0-2 aastat/2-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 2-year-olds who have received 3 doses of a vaccine containing diphtheria, tetanus, polio, Hib, hepatitis B and pertussis components aged 0-2 years/number of 2-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":14,"VaccineAbbreviation":"HPV1","TargetDiseaseCode":"203","AgeGroup":"13a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"13-aastaste arv, kes said HPV1 vaktsiini (Gardasil9)/13-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 13-year-olds who received HPV1 vaccine (Gardasil9)/Number of 13-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":34,"VaccineAbbreviation":"MMR2","TargetDiseaseCode":"108","AgeGroup":"14a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"14-aastaste arv, kellele on manustatud 2 doosi MMR vaktsiini vanuses 1-14 aastat/14-aastaste arv *100","VaccineAbbreviationsDescriptionEng":"Number of 14-year-olds who have received 2 doses of MMR vaccine aged 1-14 years/number of 14-year-olds *100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":19,"VaccineAbbreviation":"HPV1","TargetDiseaseCode":"203","AgeGroup":"12a","Gender":"Female","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"12-aastaste tütarlaste arv, kes said HPV1 vaktsiini (Gardasil9)/12-aastaste tütarlaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 12-year-old girls who received HPV1 vaccine (Gardasil9)/Number of 12-year-old girls*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":48,"VaccineAbbreviation":"DTaP-IPV-Hib-HepB3","TargetDiseaseCode":"107","AgeGroup":"2a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"2-aastaste arv, kellele on manustatud 3 doosi difteeria, teetanuse, polio, Hib, B-viirushepatiit ja läkaköha komponenti sisaldavat vaktsiini vanuses 0-2 aastat/2-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 2-year-olds who have received 3 doses of a vaccine containing diphtheria, tetanus, polio, Hib, hepatitis B and pertussis components aged 0-2 years/number of 2-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":35,"VaccineAbbreviation":"MMR2","TargetDiseaseCode":"104","AgeGroup":"16a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"16-aastaste arv, kellele on manustatud 2 doosi MMR vaktsiini vanuses 1-16 aastat/16-aastaste arv *100","VaccineAbbreviationsDescriptionEng":"Number of 16-year-olds who have received 2 doses of MMR vaccine aged 1-16 years/number of 16-year-olds *100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":38,"VaccineAbbreviation":"MMR2","TargetDiseaseCode":"104","AgeGroup":"18a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"18-aastaste arv, kellele on manustatud 2 doosi MMR vaktsiini vanuses 1-18 aastat/18-aastaste arv *100","VaccineAbbreviationsDescriptionEng":"Number of 18-year-olds who have received 2 doses of MMR vaccine aged 1-18 years/number of 18-year-olds *100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":16,"VaccineAbbreviation":"HPV1","TargetDiseaseCode":"203","AgeGroup":"12a","Gender":"Male","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"12-aastaste poiste arv, kes said HPV1 vaktsiini (Gardasil9)/12-aastaste poiste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 12-year-old boys who said HPV1 vaccine (Gardasil9)/number of 12-year-old boys*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":25,"VaccineAbbreviation":"MMR1","TargetDiseaseCode":"108","AgeGroup":"2a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"2-aastaste arv, kellele on manustatud 1 doos leetrite, mumpsi ja punetiste komponenti sisaldavat vaktsiini vanuses 1-2 aastat/2-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 2-year-olds who have received 1 dose of measles, mumps, and rubella-containing vaccine at ages 1-2 years/number of 2-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":24,"VaccineAbbreviation":"MMR1","TargetDiseaseCode":"106","AgeGroup":"2a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"2-aastaste arv, kellele on manustatud 1 doos leetrite, mumpsi ja punetiste komponenti sisaldavat vaktsiini vanuses 1-2 aastat/2-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 2-year-olds who have received 1 dose of measles, mumps, and rubella-containing vaccine at ages 1-2 years/number of 2-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":33,"VaccineAbbreviation":"MMR2","TargetDiseaseCode":"106","AgeGroup":"14a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"14-aastaste arv, kellele on manustatud 2 doosi MMR vaktsiini vanuses 1-14 aastat/14-aastaste arv *100","VaccineAbbreviationsDescriptionEng":"Number of 14-year-olds who have received 2 doses of MMR vaccine aged 1-14 years/number of 14-year-olds *100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":2,"VaccineAbbreviation":"dT","TargetDiseaseCode":"109","AgeGroup":"18+","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"18+ inimeste arv kes on saanud viimase 10 aasta jooksul difteeria ja teetanuse komponenti sisaldavat vaktsiini (Boostrix; Adacel; Imovax d.T. Adult; Tetraxim)","VaccineAbbreviationsDescriptionEng":"Number of people 18+ who have received a vaccine containing a diphtheria and tetanus component (Boostrix; Adacel; Imovax d.T. Adult; Tetraxim) in the last 10 years","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":40,"VaccineAbbreviation":"MMR2","TargetDiseaseCode":"108","AgeGroup":"18a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"18-aastaste arv, kellele on manustatud 2 doosi MMR vaktsiini vanuses 1-18 aastat/18-aastaste arv *100","VaccineAbbreviationsDescriptionEng":"Number of 18-year-olds who have received 2 doses of MMR vaccine aged 1-18 years/number of 18-year-olds *100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":32,"VaccineAbbreviation":"MMR2","TargetDiseaseCode":"104","AgeGroup":"14a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"14-aastaste arv, kellele on manustatud 2 doosi MMR vaktsiini vanuses 1-14 aastat/14-aastaste arv *100","VaccineAbbreviationsDescriptionEng":"Number of 14-year-olds who have received 2 doses of MMR vaccine aged 1-14 years/number of 14-year-olds *100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":15,"VaccineAbbreviation":"HPV1","TargetDiseaseCode":"203","AgeGroup":"14a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"14-aastaste arv, kes said HPV1 vaktsiini (Gardasil9)/14-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 14-year-olds who received HPV1 vaccine (Gardasil9)/Number of 14-year-olds*101","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":6,"VaccineAbbreviation":"dTap5","TargetDiseaseCode":"105","AgeGroup":"7a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"7-aastaste arv, kellele on manustatud vähemalt 5 doosi difteeria, teetanuse ja läkaköha komponentide sisaldava vaktsiini vanuses 0-7-aastat, kus viimane doos oli manustatud vanuses 6-7 aastat /7-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 7-year-olds who have received at least 5 doses of a vaccine containing diphtheria, tetanus and pertussis components between the ages of 0-7 years, where the last dose was administered between the ages of 6-7 years /number of 7-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":31,"VaccineAbbreviation":"MMR1","TargetDiseaseCode":"108","AgeGroup":"8a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"8-aastaste arv, kellele on manustatud 1 doos leetrite, mumpsi ja punetiste komponenti sisaldavat vaktsiini vanuses 1-8 aastat/8-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 8-year-olds who have received 1 dose of measles, mumps, and rubella vaccine aged 1-8 years/number of 8-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":5,"VaccineAbbreviation":"dTap5","TargetDiseaseCode":"102","AgeGroup":"7a","Gender":"Total","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"Yes","VaccineAbbreviationsDescriptionEst":"7-aastaste arv, kellele on manustatud vähemalt 5 doosi difteeria, teetanuse ja läkaköha komponentide sisaldava vaktsiini vanuses 0-7-aastat, kus viimane doos oli manustatud vanuses 6-7 aastat /7-aastaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 7-year-olds who have received at least 5 doses of a vaccine containing diphtheria, tetanus and pertussis components between the ages of 0-7 years, where the last dose was administered between the ages of 6-7 years /number of 7-year-olds*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}, {"Id":20,"VaccineAbbreviation":"HPV1","TargetDiseaseCode":"203","AgeGroup":"13a","Gender":"Female","OpendataVaccinationVaccineAbbrPopulationLocationCoverage":"Yes","OpendataVaccinationVaccineAbbrEnrollmentCoverage":"No","VaccineAbbreviationsDescriptionEst":"13-aastaste tütarlaste arv, kes said HPV1 vaktsiini (Gardasil9)/13-aastaste tütarlaste arv*100","VaccineAbbreviationsDescriptionEng":"Number of 13-year-old girls who received HPV1 vaccine (Gardasil9)/Number of 13-year-old girls*100","Valid":true,"ModifiedAt":"2025-12-09T11:32:04+02:00"}]